Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03410290 · ClinicalTrials.gov registry record
Journey of Patients With Vasculitis From First Symptom to Diagnosis
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 456
- Enrollment target
NCT03410290: Completed study, sponsored by University of Pennsylvania.
NCT03410290 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 456 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03410290 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 456 participants
- Enrollment target
Study Summary
This study seeks to understand the journey that patients eventually are diagnosed with vasculitis experience in the period prior to their formal diagnosis by a healthcare provider. Data elements of interest include average time from the onset of the first symptoms to the time a diagnosis of vasculitis is confirmed. Other aims include identifying factors associated with the time to diagnosis. These factors will be divided into: a) intrinsic factors, or so-called "patient-related factors", such as the type of vasculitis symptoms, patient demographics, socioeconomic status, patients' beliefs regarding the etiology of their symptoms, and other factors, and b) extrinsic factors, or "professional/health system factors", such as healthcare access, referral patterns, testing patterns, and other factors. Understanding such factors can guide future efforts to shorten delays in diagnosis and thereby improve outcomes. All analyses will be done for the population of patients with vasculitis as a whole and by individual types of vasculitis.
Primary Outcome
Analysis of how people fill in the questionnaire to determine the time from onset of symptoms of vasculitis to the first encounter with a healthcare provider for evaluation of those symptoms.
Interventions
- OTHER Online Questionnaire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 456 participants |
| Start Date | 2018-01-11 |
| Est. Completion | 2018-05-21 |
What the finished NCT03410290 record still lists
NCT03410290 is an observational study that tracks outcomes without assigning an intervention. The registered 456 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Online Questionnaire is the first listed.
NCT03410290 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03410290 about?
NCT03410290 is a clinical study titled "Journey of Patients With Vasculitis From First Symptom to Diagnosis". This study seeks to understand the journey that patients eventually are diagnosed with vasculitis experience in the period prior to their formal diagnosis by a healthcare provider. Data elements of interest include average time from the onset of the first symptoms to the time a diagnosis of vasculit...
What is the current status of trial NCT03410290?
This trial is currently completed. The enrollment target is 456 participants. The study started on 2018-01-11. Estimated completion is 2018-05-21.
What interventions are being tested in trial NCT03410290?
The interventions under investigation include: Online Questionnaire (OTHER).
Who is sponsoring clinical trial NCT03410290?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04462302 · 456 participants · NA
An Internet-based Program to Help Cancer Survivors Manage Pain
- NCT05820919 · 456 participants · NA
Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase
- NCT06254612 · 456 participants · Phase 2
A Study of the Efficacy and Safety of SP-624 in the Treatment of Adults With Major Depressive Disorder
- NCT06457841 · 456 participants · NA
Stress and Resilience
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI